A detailed history of Exane Derivatives transactions in Beyond Meat, Inc. stock. As of the latest transaction made, Exane Derivatives holds 309 shares of BYND stock, worth $1,096. This represents 0.0% of its overall portfolio holdings.

Number of Shares
309
Previous 2,311 86.63%
Holding current value
$1,096
Previous $111,000 93.69%
% of portfolio
0.0%
Previous 0.03%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

SELL
$22.27 - $51.44 $44,584 - $102,982
-2,002 Reduced 86.63%
309 $7,000
Q1 2022

Apr 22, 2022

SELL
$36.17 - $70.83 $8,499 - $16,645
-235 Reduced 9.23%
2,311 $111,000
Q4 2021

Jan 28, 2022

SELL
$63.26 - $108.62 $28,530 - $48,987
-451 Reduced 15.05%
2,546 $165,000
Q3 2021

Oct 26, 2021

BUY
$105.26 - $152.99 $49,051 - $71,293
466 Added 18.41%
2,997 $315,000
Q2 2021

Jul 28, 2021

SELL
$101.52 - $157.49 $86,901 - $134,811
-856 Reduced 25.27%
2,531 $398,000
Q1 2021

Apr 30, 2021

BUY
$116.64 - $192.08 $24,144 - $39,760
207 Added 6.51%
3,387 $440,000
Q4 2020

Jan 27, 2021

BUY
$124.74 - $194.95 $396,673 - $619,941
3,180 New
3,180 $397,000

Others Institutions Holding BYND

About BEYOND MEAT, INC.


  • Ticker BYND
  • Exchange NASDAQ
  • Sector Consumer Defensive
  • Industry Packaged Foods
  • Shares Outstandng 63,667,700
  • Market Cap $226M
  • Description
  • Beyond Meat, Inc. manufactures, markets, and sells plant-based meat products in the United States and internationally. The company sells a range of plant-based meat products across the platforms of beef, pork, and poultry. It sells its products through grocery, mass merchandiser, club store, convenience store and natural retailer channels, and d...
More about BYND
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.